Frank Karbe

Chief Financial Officer at Cidara Therapeutics · 5 reported transactions in 2 companies · latest report May 19, 2026

Their trades


Phathom PharmaceuticalsPHAT	Share award — · 24,122 shares	May 19, 2026
Cidara TherapeuticsCDTX	Returned to company — · 43,125 shares	Jan 7, 2026
Cidara TherapeuticsCDTX	Returned to company $1.67M · 7,526 shares	Jan 7, 2026
Cidara TherapeuticsCDTX	Shares withheld for tax $1.6M · 7,290 shares	Dec 10, 2025
Phathom PharmaceuticalsPHAT	Share award — · 10,500 shares	Jun 3, 2025

May 19, 2026 · PHAT

24,122

Jan 7, 2026 · CDTX

43,125

Jan 7, 2026 · CDTX

$1.67M

Shares withheld for taxCidara Therapeutics

Dec 10, 2025 · CDTX

$1.6M

Jun 3, 2025 · PHAT

10,500

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Cidara Therapeutics · 5 reported transactions in 2 companies · latest report May 19, 2026


Phathom PharmaceuticalsPHAT	Share award — · 24,122 shares	May 19, 2026
Cidara TherapeuticsCDTX	Returned to company — · 43,125 shares	Jan 7, 2026
Cidara TherapeuticsCDTX	Returned to company $1.67M · 7,526 shares	Jan 7, 2026
Cidara TherapeuticsCDTX	Shares withheld for tax $1.6M · 7,290 shares	Dec 10, 2025
Phathom PharmaceuticalsPHAT	Share award — · 10,500 shares	Jun 3, 2025